NICE endorses Magtrace diagnostic to detect breast cancer spread
pharmaphorum
MAY 18, 2022
The diagnostic developed by UK firm Endomag can be used to detect ‘sentinel’ lymph nodes – the first lymph node to which cancer cells are most likely to spread from a primary tumour – showing if the cancer has progressed beyond the breast tissue.
Let's personalize your content